Trial Profile
Pilot Study for the Evaluation of the Effects of Insulin Treatment on Myocardial Function, Perfusion, and Glucose Metabolism in Patients With Primary Left Ventricular Dysfunction and Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 01 Jul 2008 Status changed form in progress to completed, reported by ClinicalTrials.gov.
- 05 Oct 2007 Status change from recruiting to in progress
- 19 Sep 2006 New trial record.